CMND Clearmind Medicine Inc.
Price Chart
Executive Summary
Clearmind Medicine's registration statement on Form F-3 (File No. 333-295455) was declared effective by the SEC on May 7, 2026. This effectiveness allows the company to sell securities under a shelf registration, creating potential dilution overhang. The filing follows prior F-1 registrations covering warrant-related share resales by selling shareholders, and the company's micro-cap status ($1M market cap) amplifies the impact of any future offering.
Actionable Insight
The effective shelf registration gives Clearmind the ability to raise capital at any time, creating persistent overhang for a stock with only a $1M market cap. Traders should watch for any subsequent prospectus supplement or takedown announcement, which would likely pressure the stock further. The prior F-1 resale registrations also remain live, adding to the overhang.
Key Facts
- SEC declared Form F-3 registration effective on May 7, 2026 (File No. 333-295455).
- Clearmind Medicine is a micro-cap with a market capitalization of approximately $1M.
- Prior F-1/A (filed Dec 5, 2025) and F-1 (filed Nov 26, 2025) registered resale of up to 12,545,230 and 5,781,250 common shares, respectively, upon exercise of warrants.
- The company is an emerging growth company and foreign private issuer.
- Stock closed at $0.111 on Dec 3, 2025, per the F-1/A prospectus.
Financial Impact
Potential dilution from shelf registration is significant relative to the company's $1M market cap; any future offering could meaningfully increase share count.
Risk Factors
- Dilution from future shelf takedowns or warrant exercises could be highly material given the micro-cap size.
- The company's low stock price ($0.111 as of Dec 3, 2025) and micro-cap status increase vulnerability to any selling pressure.
- Historical performance shows poor T+5 outcomes on prior reports, suggesting the stock is prone to sharp moves on news.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001546 |
| Document: 9999999995-26-001546-index.html | 9999999995-26-001546 |
| Document: 9999999995-26-001546.txt | 9999999995-26-001546 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
4d ago
|
Press Release
| $2.76 awaiting T+5 | awaiting T+5 | — | $3.79 (+37.32%) |
|
May 29, 2026
11d ago
|
6-K
| $3.58 $2.91 | ▼ −18.72% | ▼ −18.42% | $3.79 (+5.87%) |
|
May 29, 2026
11d ago
|
Press Release
| $3.58 $2.91 | ▼ −18.72% | ▼ −18.42% | $3.79 (+5.87%) |
|
May 26, 2026
14d ago
|
6-K
| $2.59 $3.17 | ▲ +22.39% | ▲ +21.31% | $3.79 (+46.33%) |
|
May 26, 2026
14d ago
|
Press Release
| $2.59 $3.17 | ▲ +22.39% | ▲ +21.31% | $3.79 (+46.33%) |
|
May 19, 2026
21d ago
|
6-K
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.79 (−60.59%) |
|
May 19, 2026
21d ago
|
6-K
| $2.36 $2.58 | ▲ +9.28% | ▲ +7.04% | $3.79 (+60.59%) |
|
May 19, 2026
21d ago
|
Press Release
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.79 (−60.59%) |
|
May 18, 2026
22d ago
|
6-K
| $2.36 $2.58 | ▼ −9.28% | ▼ −7.04% | $3.79 (−60.59%) |
|
May 18, 2026
22d ago
|
6-K
| $2.36 $2.58 | ▲ +9.28% | ▲ +7.04% | $3.79 (+60.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access